home › event - sensitive location and characterization of circulating tumor cells for improving therapy selection and monitoring treatment efficacy

EVENT:

Sensitive location and characterization of circulating tumor cells for improving therapy selection and monitoring treatment efficacy
Conferences & Talks

NCI Translates: NCI Translational Science Meeting

8 November 2008
Washington, D.C., USA

 

description

For metastatic disease, biomarker profiling of distant metastases is done only when feasible because biopsy of metastases is invasive and associated with potential morbidity without proven benefit. So although biomarker expression may differ in distant metastases, treatment with targeted therapies is almost always based on biomarker targets derived from a patient¹s primary breast tumor, usually excised years before development of metastatic disease. Circulating tumor cells (CTCs) in the blood have been linked to disease outcome in patients with metastatic breast cancer...We have developed a sensitive CTC detection tool using Fiber Array Scanning Technology (FAST) that can rapidly locate CTCs on a substrate and uses abundant cytokeratins not EpCAM as targets. We have developed a protocol that enables testing for protein expression of 5 markers in addition to the ones needed for CTC identification.

 

upcoming events   view all 

Aston Martin: The Brand Journey of a 100 Year-old Startup
Mr. Simon Sproule
29 August 2016
PARC Forum  

A Low-cost and Innovative Radar “Digital Eye”
Bernard Casse
20 September 2016 - 22 September 2016 | Brussels, Belgium
Conferences & Talks  

Stanford and PARC host Digital Cities Summit 2016
Victoria Bellotti, Panel Facilitator, Bernard Casse, Panelist, Sean Garner, Panelist, Stephen Hoover, Keynote Speaker, Matthew Klenk, Tolga Kurtoglu, Panel Facilitator, Markus Larsson, Speaker, Ersin Uzun, Panelist
3 October 2016 - 4 October 2016 | Stanford, CA
Conferences & Talks